Search Results - von Broen, I.-M.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours

    An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours by Awada, A, Thödtmann, R, Piccart, M.J, Wanders, J, Schrijvers, A.H.G.J, Von Broen, I.-M, Hanauske, A.R

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Clinical and pharmacoklnetic evaluation of the new blsnaphtalamlde LU 79553 administered every 21 days in patients with solid tumors: An EORTC/ECSG study

    Clinical and pharmacoklnetic evaluation of the new blsnaphtalamlde LU 79553 administered every 21 days in patients with solid tumors: An EORTC/ECSG study by Thōdtmann, R., Awada, A., Piccart, M., Höppener, F., Wanders, J., von Broen, I.-M., Hanauske, A.-R.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: